- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Public drug program spending in Canada by therapy share 2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Public drug program spending in Canada by therapy share 2017
Distribution of total public drug program spending in Canada by therapy in 2017*
by Matej Mikulic,
last edited
Nov 26, 2018
This statistic shows the proportion of the total public drug program expenditures in Canada by broad therapeutic category in 2017. In that year, over 19 percent of total drug program spending was dedicated to antineoplastic and immunomodulating agents.
Distribution of total public drug program spending in Canada by therapy in 2017*
| Share of total public drug spending | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Share of total public drug spending | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Nov 26, 2018
This statistic shows the proportion of the total public drug program expenditures in Canada by broad therapeutic category in 2017. In that year, over 19 percent of total drug program spending was dedicated to antineoplastic and immunomodulating agents.
- Show sources information
- Show publisher information
- Release date
- November 2018
- Region
- Canada
- Survey time period
- 2017
- Supplementary notes
-
* Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.
** This category includes products without an assigned Anatomical Therapeutic Chemical (ATC) code.
Source
- Show sources information
- Show publisher information
- Release date
- November 2018
More information
- Region
- Canada
- Survey time period
- 2017
- Supplementary notes
-
* Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.
** This category includes products without an assigned Anatomical Therapeutic Chemical (ATC) code.
Other statistics on the topic
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Health expenditures in the U.S."
- Global comparison
The most important statistics
- Global health spending per capita in 2016 and projections for 2050 (in U.S. dollars)*Estimated global per capita health spending in 2016 and 2050
- Per capita health expenditure in selected countries in 2017 (in U.S. dollars)*Per capita health expenditure in selected countries 2017
- Health expenditure as a percentage of gross domestic product in selected countries in 2017Health expenditure as a percentage of GDP in select countries 2017
- Public and private per capita health expenditure in selected countries in 2016 (in U.S. dollars)Public and private per capita health expenditure in selected countries 2016
- Countries with the highest share of domestic governmental health expenditure in 2016*Countries with highest government health expenditure share 2016
- Overview U.S.
The most important statistics
- U.S. national health expenditure from 1960 to 2019 (in billion U.S. dollars)U.S. national health expenditure 1960-2019
- National per capita health expenditure in the United States from 1960 to 2019 (in U.S. dollars)U.S. national health expenditure per capita 1960-2019
- U.S. national health expenditure as percent of GDP from 1960 to 2019U.S. health expenditure as percent of GDP 1960-2019
- Average annual percent change in U.S. national health expenditure from 1960 to 2017*Average annual change in U.S. national health expenditure 1960-2017
- Categories
The most important statistics
- Health spending distribution in the United States from 2013 to 2017, by category*Health spending distribution in the United States by category 2013-2017
- Health spending growth rate in the United States from 1997 to 2017, by categoryHealth spending growth rate in the U.S. 1997-2017 sorted by category
- Annual growth in selected health spending categories in the United States from 2010 to 2017Growth in health spending categories in the U.S. 2010-2017
- Health spending distribution in the United States 2014-2017 and projections for 2027, by payer*Health spending distribution in the United States by payer 2014-2027
- Payer
The most important statistics
- Distribution of U.S. health care expenditure from 2014 to 2018, by payerU.S. health care expenditure distribution by payer 2014-2018
- Annual change in health spending levels in the United States in 2017, by payerChange in health spending levels in the United States by payer 2017
- Hospital care services spending in the United States from 2013 to 2017, by payer (in billion U.S. dollars)Hospital care spending in the United States by payer 2013-2017
- Prescription drugs spending in the United States from 2013 to 2017, by payer (in billion U.S. dollars)Prescription drugs spending in the U.S. by payer 2013-2017
- Out-of-pocket
The most important statistics
- Total out-of-pocket health care payments in the United States from 1960 to 2019 (in billion U.S. dollars)U.S. total out-of-pocket health care payments 1960-2019
- Per capita out-of-pocket health care payments in the United States from 2010 to 2019 (in U.S. dollars)U.S. per capita out-of-pocket health care payments 2010-2019
- Out-of-pocket share of total personal health care expenditures in the U.S. from 2010 to 2019Out-of-pocket share of total U.S. personal health care expenditures 2010-2019
- Annual change of out-of-pocket health care payments in the U.S. from 2011 to 2019U.S. out-of-pocket health care payments annual change 2011-2019
- Health spending distribution of private insurance and out-of-pocket payments in the United States in 2017*Health costs distribution of private insurance and out-of-pocket payments U.S. 2017
- NHE projections
The most important statistics
- Forecasted U.S. national health expenditure from 2020 to 2027 (in billion U.S. dollars)U.S. national health expenditure forecast 2020-2027
- Forecasted national per capita health expenditure in the United States from 2020 to 2027 (in U.S. dollars)U.S. national health expenditure per capita 2020-2027
- Forecasted U.S. national health expenditure as percent of GDP from 2020 to 2027U.S. health expenditure as percent of GDP 2020-2027
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Public drug program spending in Canada by top 10 drug classes 2017
- Public drug program spending in Canada by top drug classes 2017
- Private sector funded drug spending Canada by top drug classes share 2013
- Total public drug program spending in Canada by therapy 2017
- Share of paid beneficiaries of public drug program spending in Canada 2017
- Private sector funded total drug spending in Canada by top drug classes 2013
- Public drug program spending share for non-seniors in Canada by province 2017
- Public drug program spending share for seniors in Canada by province 2017
- Public drug program spending for non-seniors in Canada by top drug classes 2017
- Public drug program spending for seniors in Canada by top drug classes 2017
- Public drug program spending share for seniors in Canada by top drug classes 2017
- Public drug program spending share for generics in Canada by province 2017
- Drug spending by Rx and non-Rx in Canada by type 1975-2018
- U.S. spending on specialty medicine by type 2014-2018
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- Expenditures dedicated to drugs as share of total health spending in Canada 2005-2018
- U.S. spending on therapeutic oncology and supportive care by type 2011-2015
- U.S. spending on biosimilars by type 2014
- Drug spending as percent of total health in Canada by province 2018
Studies
- Prescribed Drug Spending in Canada, 2018
- CDER 2018 New Drug Therapy Approvals
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Drug Use Among Seniors in Canada, 2016
- CDER 2017 New Drug Therapy Approvals
- Prescribed Drug Spending in Canada, 2017
- Meds Entry Watch 2017
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- The Oregon Medical Marijuana Program (April 2019)
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Patented Medicine Prices Review Board - Annual Report 2017
- Meds Entry Watch 2016
- Compass Rx - Annual Public Drug Plan Expenditure Report 2013/14
- Compass Rx - Annual Public Drug Plan Expenditure Report 2015/16
- Prescribed Drug Spending in Canada, 2013
Statistics on "Health expenditures in the U.S."
- Global health spending per capita in 2016 and projections for 2050 (in U.S. dollars)*
- Per capita health expenditure in selected countries in 2017 (in U.S. dollars)*
- Health expenditure as a percentage of gross domestic product in selected countries in 2017
- Public and private per capita health expenditure in selected countries in 2016 (in U.S. dollars)
- Countries with the highest share of domestic governmental health expenditure in 2016*
- U.S. national health expenditure from 1960 to 2019 (in billion U.S. dollars)
- National per capita health expenditure in the United States from 1960 to 2019 (in U.S. dollars)
- U.S. national health expenditure as percent of GDP from 1960 to 2019
- Average annual percent change in U.S. national health expenditure from 1960 to 2017*
- Health spending distribution in the United States from 2013 to 2017, by category*
- Health spending growth rate in the United States from 1997 to 2017, by category
- Annual growth in selected health spending categories in the United States from 2010 to 2017
- Health spending distribution in the United States 2014-2017 and projections for 2027, by payer*
- Distribution of U.S. health care expenditure from 2014 to 2018, by payer
- Annual change in health spending levels in the United States in 2017, by payer
- Hospital care services spending in the United States from 2013 to 2017, by payer (in billion U.S. dollars)
- Prescription drugs spending in the United States from 2013 to 2017, by payer (in billion U.S. dollars)
- Total out-of-pocket health care payments in the United States from 1960 to 2019 (in billion U.S. dollars)
- Per capita out-of-pocket health care payments in the United States from 2010 to 2019 (in U.S. dollars)
- Out-of-pocket share of total personal health care expenditures in the U.S. from 2010 to 2019
- Annual change of out-of-pocket health care payments in the U.S. from 2011 to 2019
- Health spending distribution of private insurance and out-of-pocket payments in the United States in 2017*
- Forecasted U.S. national health expenditure from 2020 to 2027 (in billion U.S. dollars)
- Forecasted national per capita health expenditure in the United States from 2020 to 2027 (in U.S. dollars)
- Forecasted U.S. national health expenditure as percent of GDP from 2020 to 2027
- Top 10 drug classes by total public drug program spending in Canada in 2017 (in million Canadian dollars)*
- Top 10 drug classes by share of total public drug program spending in Canada in 2017*
- Top 10 drug classes by share of total drug spending funded by private sector in Canada in 2013*
- Total public drug program spending in Canada by therapy in 2017 (in million Canadian dollars)
- Distribution of paid beneficiaries from total public drug program spending in Canada in 2017*
- Top 10 drug classes by total drug spending funded by private sector in Canada in 2013 (in million Canadian dollars)
- Distribution of total public drug program spending on non-seniors in Canada by province in 2017*
- Distribution of total public drug program spending on seniors in Canada by province in 2017*
- Top 10 drug classes in Canada by total public drug program spending on non-seniors in 2017 (in million Canadian dollars)
- Top 10 drug classes in Canada by total public drug program spending on seniors in 2017 (in million Canadian dollars)*
- Distribution of top 10 drug classes in Canada by public drug program spending on seniors in 2017*
- Generic drugs share of total public drug program spending in Canada by province in 2017*
- Expenditure on prescribed and non-prescribed drugs in Canada from 1975 to 2018 (in million Canadian dollars)
- Expenditure on specialty medicines in the United States from 2014 to 2018, by type (in billion U.S. dollars)
- Spending growth on new brand specialty medicines in the United States in 2014 and 2015, by type (in billion U.S. dollars)
- Expenditure on multiple sclerosis medicines in the United States from 2010 to 2014, by type (in billion U.S. dollars)
- Expenditure on drugs as percent of total health spending in Canada from 2005 to 2018
- Expenditure on therapeutic oncology and supportive care in the United States from 2011 to 2015, by type (in billion U.S. dollars)
- Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*
- Drug expenditure as percentage of total health spending in Canada by province in 2018*
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.